Gallstone Symptom Risk Calculator
Surgery is an important decision.
Evidence-Led Decision Support
Move beyond generalities. Understand the research.
Elevating the Standard of Care
Every patient’s journey with gallstone disease is unique, yet many treatment decisions are made without looking at the fine print. To provide a higher standard of care, I believe in Evidence-Based Precision—using high-quality research to navigate your choices.
Why this matters: Not all gallstones carry the same risk of causing an emergency while you wait. I developed this Interactive Evidence Explorer because I believe my patients deserve to understand the data behind the decision.
By analyzing the RELAPSTONE study (tracking 3,000+ patients who did not have surgery), we can see that specific profiles carry higher risks than others. Using this insight, I can offer you a consultation that isn't just about "booking a procedure," but about building a safe, prioritized clinical strategy tailored to your needs.
Consider bringing your report to your consultation with Mr. Rahman
Gallstone Evidence Explorer
Visualising the RELAPSTONE (2024) Multicentre Study Cohort.
Clinical Evidence Summary
Mr Saqib Rahman PhD FRCS
Consultant Biliary & Hernia Surgeon
Private Practice Service
1. Scenario Profile
2. Visualised Outcomes (12-Month Kaplan-Meier)
3. Consultation Notes
-
Evidence Source: The RELAPSTONE Study The data shown here is derived from a large-scale international multicentre study of 3,016 patients. The researchers identified several independent prognostic factors that were statistically associated with a higher likelihood of symptoms returning while waiting for surgery:
Stone Burden: In the study, patients with multiple gallstones had a higher recurrence rate (HR 1.19).
Liver Biochemistry (ALT): Elevated ALT levels at presentation were a key marker for relapse in the trial cohort (HR 1.22).
Age Trends: Data indicated that younger patients in the study often displayed higher symptomatic recurrence rates than older cohorts.
Ductal Clearance: A history of ERCP was found to be a protective factor within the research group.
-
Regulatory Statement & Purpose: This tool is an Interactive Clinical Reference intended for professional and patient education. It visualises population-level data from a published retrospective cohort and does not perform a personalised clinical risk prediction, diagnosis, or treatment recommendation.
Limitations: Not a Medical Device: This tool provides a visual interface for peer-reviewed literature; it is not a validated medical device for individual prognosis.
Statistical Probability: The results represent trends within a specific research population. Individual outcomes vary based on anatomy, comorbidities, and clinical presentation.
Consultation Required: All symptomatic gallstones carry a baseline risk of complications. Use this report to facilitate a formal clinical consultation with Mr Saqib Rahman.
The interactive tools on this site are for educational purposes only. They visualise population data from peer-reviewed clinical trials (RELAPSTONE 2024) and do not provide personalised medical diagnosis or treatment predictions. All surgical decisions must be made in consultation with Mr Saqib Rahman.
Decided to proceed? Now that you understand your risks, use our Recovery Planner to see exactly when you can return to driving, work, and holidays after your operation.